Loading...
Rivaroxaban Delivery and Reversal at a Venous Flow Rate
OBJECTIVE: Rivaroxaban is an oral anticoagulant that directly targets both free factor Xa and factor Xa in complex with its protein cofactor, factor Va, in the prothrombinase complex. It is approved in the United States for the prophylaxis of deep vein thrombosis and stroke in patients with atrial f...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629550/ https://ncbi.nlm.nih.gov/pubmed/23023369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.112.300053 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|